Rasha Omr Abd Elmonem Ahmed
Asst. Professor
Levels of GLP-1 In Response to The Most Common Used Bariatric Procedures in Obese Patients with Type 2 Diabetes Mellitus
• 2026
Publication Information
Authors
Amira M. Elsayed*1
, Walaa M. lbrahim1
, Ahmed M.F.Salama2
,
Maha H.Morsy4
, Eman M. Araby3
, Rasha O. Abdelmoniem1
.
Keywords
Not Available
Journal
Not Available
Publisher
Not Available
Volume
Not Available
Issue
Not Available
Pages
Not Available
publication.type
Local
Paper Link
Not Available
Supplementary Materials
Not Available
Abstract
Background: In the last two decades, extreme obesity and its comorbidities have often been treated with bariatric
surgery.
Objective: Our goal was to compare the levels of GLP-1 in individuals who are severely obese three months after
undergoing any of the three more frequent bariatric methods: sleeve gastrectomy (SG), Roux en Y gastric bypass
(RYGB), or intragastric balloon (IGB).
Patients and Methods: This is prospective research being done at Benha University Hospital for people with obesity
and type 2 diabetes who have been recruited 3 months prior to having any bariatric surgeries. Patients were subjected
to measurement of WC, BMI and laboratory assay of HbA1c, fasting plasma glucose (FPG), fasting insulin, HOMAIR, ALT, AST, glucagon-like peptide-1 (GLP-1) and lipid profile before and after 3 months of procedures.
Results: There was significant improvement of FPG, and HbA1c in RYGB operation in comparison with other bariatric
procedures. Fasting insulin was substantially lower in the RYGB surgery than the in SG and IGB (p ˂ 0.05) with
substantial improvements of HOMA-IR for RYGB surgery (p ˂ 0.05). In RYGB surgery, there was highly substantial
increase in GLP-1 levels compared to SG and IGB procedures (p
surgery.
Objective: Our goal was to compare the levels of GLP-1 in individuals who are severely obese three months after
undergoing any of the three more frequent bariatric methods: sleeve gastrectomy (SG), Roux en Y gastric bypass
(RYGB), or intragastric balloon (IGB).
Patients and Methods: This is prospective research being done at Benha University Hospital for people with obesity
and type 2 diabetes who have been recruited 3 months prior to having any bariatric surgeries. Patients were subjected
to measurement of WC, BMI and laboratory assay of HbA1c, fasting plasma glucose (FPG), fasting insulin, HOMAIR, ALT, AST, glucagon-like peptide-1 (GLP-1) and lipid profile before and after 3 months of procedures.
Results: There was significant improvement of FPG, and HbA1c in RYGB operation in comparison with other bariatric
procedures. Fasting insulin was substantially lower in the RYGB surgery than the in SG and IGB (p ˂ 0.05) with
substantial improvements of HOMA-IR for RYGB surgery (p ˂ 0.05). In RYGB surgery, there was highly substantial
increase in GLP-1 levels compared to SG and IGB procedures (p